{
  "query_term": "CARVYKTI (Ciltacabtagene autoleucel)",
  "total_count": 4,
  "returned": 4,
  "kept": 1,
  "studies": [
    {
      "nct_id": "NCT05346835",
      "title": "Intermediate-Size Population Expanded Access Program (EAP) for Ciltacabtagene Autoleucel (Cilta-cel) Out-of-Specification (OOS) in Patients With Multiple Myeloma",
      "overall_status": "AVAILABLE",
      "phase": null,
      "conditions": [
        "Multiple Myeloma"
      ],
      "lead_sponsor": "Janssen Scientific Affairs, LLC",
      "collaborators": [],
      "interventions": [
        "Cilta-cel OOS Therapy"
      ],
      "last_update": "2025-08-27",
      "ctgov_url": "https://clinicaltrials.gov/study/NCT05346835"
    }
  ]
}